424 related articles for article (PubMed ID: 27423483)
1. Neuroleptic Malignant Syndrome.
Pileggi DJ; Cook AM
Ann Pharmacother; 2016 Nov; 50(11):973-981. PubMed ID: 27423483
[TBL] [Abstract][Full Text] [Related]
2. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
Perry PJ; Wilborn CA
Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
[TBL] [Abstract][Full Text] [Related]
3. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic malignant syndrome.
Caroff SN; Mann SC
Med Clin North Am; 1993 Jan; 77(1):185-202. PubMed ID: 8093494
[TBL] [Abstract][Full Text] [Related]
6. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome and clozapine.
Reddig S; Minnema AM; Tandon R
Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
[TBL] [Abstract][Full Text] [Related]
8. The neuroleptic malignant syndrome-a systematic case series analysis focusing on therapy regimes and outcome.
Kuhlwilm L; Schönfeldt-Lecuona C; Gahr M; Connemann BJ; Keller F; Sartorius A
Acta Psychiatr Scand; 2020 Sep; 142(3):233-241. PubMed ID: 32659853
[TBL] [Abstract][Full Text] [Related]
9. [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].
Chackupurakal R; Wild U; Kamm M; Wappler F; Reske D; Sakka SG
Anaesthesist; 2015 Jul; 64(7):527-31. PubMed ID: 26122200
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic malignant syndrome due to olanzapine.
Hall KL; Taylor WH; Ware MR
Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene.
Kouparanis A; Bozikas A; Spilioti M; Tziomalos K
Brain Inj; 2015; 29(5):658-60. PubMed ID: 25625410
[TBL] [Abstract][Full Text] [Related]
12. [Neuroleptic malignant syndrome. Case reports].
Berardi D; Troia M; Veronesi L; Ferrari G
Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review.
Wells AJ; Sommi RW; Crismon ML
Drug Intell Clin Pharm; 1988 Jun; 22(6):475-80. PubMed ID: 2899492
[TBL] [Abstract][Full Text] [Related]
14. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome associated with clozapine treatment.
Tsai G; Crisostomo G; Rosenblatt ML; Stern TA
Ann Clin Psychiatry; 1995 Jun; 7(2):91-5. PubMed ID: 8556099
[TBL] [Abstract][Full Text] [Related]
16. [Neuroleptic malignant syndrome].
Knorr R; Schöllkopf J; Haen E
Nervenarzt; 2018 Mar; 89(3):300-310. PubMed ID: 29209753
[TBL] [Abstract][Full Text] [Related]
17. The neuroleptic malignant syndrome: agent and host interaction.
Shalev A; Munitz H
Acta Psychiatr Scand; 1986 Apr; 73(4):337-47. PubMed ID: 2873715
[TBL] [Abstract][Full Text] [Related]
18. Clozapine Rechallenge Following Neuroleptic Malignant Syndrome: A Systematic Review.
Lally J; McCaffrey C; OʼMurchu C; Krivoy A; Guerandel A; MacCabe JH; Gaughran F
J Clin Psychopharmacol; 2019; 39(4):372-379. PubMed ID: 31205196
[TBL] [Abstract][Full Text] [Related]
19. [Neuroleptic malignant syndrome].
Murak E
Psychiatr Pol; 1995; 29(3):349-58. PubMed ID: 7652088
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome in cancer treatment.
Kawanishi C; Onishi H; Kato D; Yamada T; Onose M; Hirayasu Y
Palliat Support Care; 2005 Mar; 3(1):51-3. PubMed ID: 16594195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
